Literature DB >> 30603347

Japanese Clinical Practice Guideline for Diabetes 2016.

Masakazu Haneda1, Mitsuhiko Noda2, Hideki Origasa3, Hiroshi Noto4, Daisuke Yabe5, Yukihiro Fujita1, Atsushi Goto6, Tatsuya Kondo7, Eiichi Araki7.   

Abstract

Entities:  

Keywords:  Diabetes; Diagnosis; Guideline; Treatment

Year:  2018        PMID： 30603347      PMCID： PMC6224875          DOI： 10.1007/s13340-018-0345-3

Source DB:  PubMed          Journal:  Diabetol Int        ISSN： 2190-1678


× No keyword cloud information.
  271 in total

1.  Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients.

Authors:  G Charpentier; F Fleury; M Kabir; L Vaur; S Halimi
Journal:  Diabet Med       Date:  2001-10       Impact factor: 4.359

2.  Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial.

Authors:  Robert J Young; Jean Taylor; Tim Friede; Sally Hollis; James M Mason; Pauline Lee; Edna Burns; Andrew F Long; Tina Gambling; John P New; J Martin Gibson
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

3.  ISPAD Clinical Practice Consensus Guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents.

Authors:  Oscar Rubio-Cabezas; Andrew T Hattersley; Pål R Njølstad; Wojciech Mlynarski; Sian Ellard; Neil White; Dung Vu Chi; Maria E Craig
Journal:  Pediatr Diabetes       Date:  2014-09       Impact factor: 4.866

4.  Long-term effects of intensive glucose lowering on cardiovascular outcomes.

Authors:  Hertzel C Gerstein; Michael E Miller; Saul Genuth; Faramarz Ismail-Beigi; John B Buse; David C Goff; Jeffrey L Probstfield; William C Cushman; Henry N Ginsberg; J Thomas Bigger; Richard H Grimm; Robert P Byington; Yves D Rosenberg; William T Friedewald
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

5.  Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.

Authors:  D Einhorn; M Rendell; J Rosenzweig; J W Egan; A L Mathisen; R L Schneider
Journal:  Clin Ther       Date:  2000-12       Impact factor: 3.393

6.  2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Thom W Rooke; Alan T Hirsch; Sanjay Misra; Anton N Sidawy; Joshua A Beckman; Laura K Findeiss; Jafar Golzarian; Heather L Gornik; Jonathan L Halperin; Michael R Jaff; Gregory L Moneta; Jeffrey W Olin; James C Stanley; Christopher J White; John V White; R Eugene Zierler
Journal:  J Am Coll Cardiol       Date:  2011-10-06       Impact factor: 24.094

Review 7.  Evidence-based management of hyperglycemic emergencies in diabetes mellitus.

Authors:  Ebenezer A Nyenwe; Abbas E Kitabchi
Journal:  Diabetes Res Clin Pract       Date:  2011-10-05       Impact factor: 5.602

8.  Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

Authors:  Yoon K Loke; Sonal Singh; Curt D Furberg
Journal:  CMAJ       Date:  2008-12-10       Impact factor: 8.262

9.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

10.  Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy.

Authors:  Henrik Post Hansen; Ellis Tauber-Lassen; Berit R Jensen; Hans-Henrik Parving
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612
View more
  65 in total

Review 1.  The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes.

Authors:  Mads Frederik Rasmussen
Journal:  Diabetol Int       Date:  2020-01-04

2.  Effect of tasteless calorie-free gum chewing before meal on postprandial plasma glucose, insulin, glucagon, and gastrointestinal hormones in Japanese men without diagnosed glucose metabolism disorder: a pilot randomized crossover trial.

Authors:  Mitsuyoshi Takahara; Masahiro Fukuda; Yuji Matsuzawa; Iichiro Shimomura
Journal:  Diabetol Int       Date:  2020-04-11

3.  Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.

Authors:  Sadayoshi Ito; Kenichi Shikata; Masaomi Nangaku; Yasuyuki Okuda; Tomoko Sawanobori
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-27       Impact factor: 8.237

4.  Protein arginine N-methyltransferase 1 gene polymorphism is associated with proliferative diabetic retinopathy in a Japanese population.

Authors:  Hiroaki Iwasaki; Masayoshi Shichiri
Journal:  Acta Diabetol       Date:  2021-10-14       Impact factor: 4.280

5.  Prospective study on clinical characteristics of Japanese diabetic patients with chronic limb-threatening ischemia presenting Fontaine stage IV.

Authors:  Mitsuyoshi Takahara; Shota Okuno; Izumi Nakamura; Osamu Iida; Takuya Tsujimura; Yosuke Hata; Yukihiro Fujita; Masakazu Haneda
Journal:  Diabetol Int       Date:  2019-06-17

6.  Type 2 diabetes mellitus complicated with idiopathic hypoparathyroidism where poor glycaemic control was associated with low adherence to exercise and medication due to hypocalcaemia.

Authors:  Tomomi Ueda; Yuya Tsurutani; Sho Katsuragawa; Jun Saito
Journal:  BMJ Case Rep       Date:  2019-12-18

7.  An evidence map of clinical practice guideline recommendations and quality on diabetic retinopathy.

Authors:  Yue Sun; Yi-Tong Cai; Ji Chen; Ya Gao; Jiangbo Xi; Long Ge; Yi Cao; Junhua Zhang; Jinhui Tian
Journal:  Eye (Lond)       Date:  2020-06-24       Impact factor: 3.775

8.  Association of proteinuria with incident atrial fibrillation in the general Japanese population.

Authors:  Yoshihiro Tanaka; Hayato Tada; Satoshi Hara; Kenshi Hayashi; Ravi B Patel; Tetsuo Nishikawa; Atsushi Hashiba; Masayuki Takamura; Philip Greenland; Masa-Aki Kawashiri
Journal:  J Cardiol       Date:  2020-08-23       Impact factor: 3.159

9.  Effect of a mobile digital intervention to enhance physical activity in individuals with metabolic disorders on voiding patterns measured by 24-h voided volume monitoring system: Kumejima Digital Health Project (KDHP).

Authors:  Minoru Miyazato; Asuka Ashikari; Koshi Nakamura; Takehiro Nakamura; Kiyoto Yamashiro; Tsugumi Uema; Moriyuki Uehara; Hiroaki Masuzaki; Seiichi Saito; Shiro Maeda; Hajime Ishida; Masayuki Matsushita
Journal:  Int Urol Nephrol       Date:  2021-04-28       Impact factor: 2.370

10.  A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents.

Authors:  Hirotaka Watada; Yasushi Kawakita; Keiko Tanaka; Akinori Oh; Nobuhiro Nishigaki; Tadashi Nakajima; Keita Fujikawa; Manabu Akazawa
Journal:  Diabetes Ther       Date:  2021-06-20       Impact factor: 2.945
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.